Somai Pharmaceuticals

CDMO

Portugal

https://somaipharma.eu/

Is this your company? Claim this profile

Drug Product

Excipients & Specialty Ingredients

Company Overview

About

Somai Pharmaceuticals is a pharmaceutical CDMO offering comprehensive services.

Key Expertise

Specialized in Formulation Development, Process Development, Scale-up

Therapeutic Areas

Oncology

Hematology

Quick Facts

HQ:Portugal

Founded:1995

Employees:2,877

Capabilities & Services

Core Capabilities

Oral Solid Dose
Solid Dose Manufacturing
Formulation Development

Types of Organization

GMP Manufacturing

Quality Systems

Regulatory Support

Dosage Forms

Lyophilized (Freeze-Dried)

Sterile Injectable

Containment Capabilities

OEB 4 (1-10 µg/m³)

Production Scales

Commercial Scale

Large Scale (Metric Ton+)

Markets Served

Global

International Regulatory

EU GMP Certificates

Regulatory Bodies

EMA/EudraGMDP

Regulatory Approvals

Drug Approval RHDFQ7

Health Canada · #APR-VEM3TGGD · 2019-10-01

Drug Approval FOL3XF

EMA · #APR-1XKQ4C9R · 2019-06-01

Case Studies

0 published case studies showcasing past projects, challenges and outcomes.

Certifications

ISO 13485:2016

International Organization for Standardization

Cert #: CERT-29IL9TP4

Issued: 2020-06-02

Expires: 2025-12-01

MHRA GMP

UK Medicines and Healthcare products Regulatory Agency

Cert #: CERT-SULM9BMO

Issued: 2020-09-21

Expires: 2025-05-23

Loading CDMO intelligence...

Request an Introduction

Please log in to contact this provider.

Key facts about Somai Pharmaceuticals

Somai Pharmaceuticals is headquartered in Portugal.
Somai Pharmaceuticals was founded in 1995.
Somai Pharmaceuticals has 2,877 employees.
Somai Pharmaceuticals's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.

Find CDMOs like Somai Pharmaceuticals

Directory pages this company appears in, each with the full list of matching manufacturers.

Oral Solid Dose CDMOs Formulation Development CDMOs Lyophilized (Freeze-Dried) CDMOs Sterile Injectable CDMOs OEB 4 (1-10 µg/m³) CDMOs